CVE-2023-40150

CVE-2023-40150 is a critical-severity vulnerability in Softneta Meddream Pacs with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-749.

Key facts

Description

Softneta MedDream PACS does not perform an authentication check and performs some dangerous functionality, which could result in unauthenticated remote code execution.0

Frequently asked questions

What is CVE-2023-40150?
Softneta MedDream PACS does not perform an authentication check and performs some dangerous functionality, which could result in unauthenticated remote code execution.0
How severe is CVE-2023-40150?
CVE-2023-40150 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-40150 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (59th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-40150?
CVE-2023-40150 affects Softneta Meddream Pacs. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-40150?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2023-40150 published?
CVE-2023-40150 was published on 2023-09-11 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Softneta Meddream Pacs

All CVEs affecting Softneta Meddream Pacs →

Other CWE-749 vulnerabilities

Browse all CWE-749 vulnerabilities →